Effect of retinoids on AOM-induced colon cancer in rats: Modulation of cell proliferation, apoptosis and aberrant crypt foci

Carcinogenesis

Volumn 20, Issue 2, 1999, Pages 255-260

  Zheng, Ye ^a   Kramer, Paula M ^a   Lubet, Ronald A ^b   Steele, Vernon E ^b   Kelloff, Gary J ^b   Pereira, Michael A ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN; AZOXYMETHANE; FENRETINIDE; RETINOID;

ADENOMA; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CHEMOPROPHYLAXIS; COLON CANCER; CONTROLLED STUDY; DIET; DRUG EFFECT; MALE; MITOSIS INDEX; MITOSIS RATE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADENOCARCINOMA; ADENOMA; ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; AZOXYMETHANE; BODY WEIGHT; CARCINOGENS; COLON; COLONIC NEOPLASMS; DRUG SCREENING ASSAYS, ANTITUMOR; FENRETINIDE; MALE; PRECANCEROUS CONDITIONS; RATS; RATS, INBRED F344; TRETINOIN;

EID: 0032953518     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.2.255     Document Type: Article

References (42)

1. Bailar, J.C. and Gornik, H.L. (1997) Cancer undefeated. N. Engl. J. Med., 336, 1569-1574.
2. World Health Organization (1997) The World Health Report. WHO, Geneva, Switzerland.
3. Boone, C.W., Kelloff, G.J. and Malone, W.E. (1990) Identification of candidate cancer chemopreventive agents and their evolution in animal models and human clinical trials: a review. Cancer Res., 50, 2-9.
4. Boone, C.W., Kelloff, G.J. and Steel, V.E. (1992) Natural history of intraepithelial neoplasia in humans with implications for cancer chemoprevention strategy. Canter Res., 52, 1651-1659.
5. Sankaranarayanan, R. and Mathew, B. (1996) Retinoids as cancer-preventive agents. IARC Scientific Publications no. 139, IARC. Lyon, pp. 47-59.
6. Lotan, R. (1996) Retinoids in cancer chemoprevention. FASEB J., 10, 1031-1039.
7. Gottardis, M.M., Lamph, W.W., Shalinsky, D.R., Wellstein, A. and Heyman, R.A. (1996) The efficacy of 9-cis retinoic acid in experimental models of cancer. Breast Cancer Res. Treatment, 38, 85-96.
8. Girod, S.C. and Pfahl, M. (1996) Retinoid actions and implications for prevention and therapy of oral cancer. Int. J. Oral Maxillofacial Surgery, 25, 69-73.
9. Sporn, M.B. and Newton, D.L. (1979) Chemoprevention of cancer with retinoids. Federation Proc., 38, 2528-2534.
10. Silverman, J., Katayama, S., Zelenakas, K., Lauber, J., Musser, T.K., Reddy, M., Levenstein, M.J. and Weisburger, J.H. (1981) Effect of retinoids on the induction of colon cancer in F344 rats by N-methyl-N-nitrosourea or by 1,2-dimethylhydrazine. Carcinogenesis, 2, 1167-1172.
11. Mathe, G., Gouveia, J., Hercend, T. et al. (1982) Correlation between precancerous bronchial metaplasia and cigarette consumption, and preliminary results of retinoids treatment. Cancer Dect. Prev., 5, 461-466.
12. Dawson, M.I., Chao, W.R. and Helmes, L.T. (1987) Inhibition by retinoids of anthralin induced mouse epidermal ornithine decarboxylase activity and anthralin-promoted skin tumor formation. Cancer Res., 47, 6210-6215.
13. Pollard, M., Luckert, P.H. and Sporn, M.D. (1991) Prevention of primary prostate cancer in Lobund-Wistar rats by N-(4-hydroxyphenyl)retinamide. Cancer Res., 51, 3610-3611.
14. Moon, R.C., Thompson, H.J., Becci, P.J. et al. (1979) N-(4-hydroxyphenyl)retinamide, a new retinoid for prevention of breast cancer in the rats. Cancer Res., 39, 1339-1346.
15. Bird, R.P. (1987) Observations and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett., 37, 147-151.
16. Pretlow, T.P., Cheter, C. and O'Riordan, M.A. (1994) Aberrant crypt foci and colon tumors in F344 rats have similar increases in proliferative activity. Int. J. Cancer, 56, 599-602.
17. Bird, P.R. (1995) Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett., 93, 55-71.
18. Roncucci, L., Stamp, D., Medline, A., Cullen, J.B. and Bruce, W.R. (1991) Identification of quantification of aberrant crypt foci and microadenomas in the human colon. Hum. Pathol., 22, 287-294.
19. Pereira, M.A. and Khoury, M.D. (1991) Prevention by chemopreventive agents of azoxymethane-induced foci of aberrant crypts in rat colon. Cancer Lett., 61, 27-33.
20. Pereira, M.A., Barnes, L.H., Rassman, V.L., Kelloff, G.V., Steele, V.E. and Lubet, R.A. (1994) Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents. Carcinogenesis. 15, 1049-1054.
21. Wargovich, M.J., Chen, C.D., Harris, C., Yang, E. and Velasco, M. (1995) Inhibition of aberrant crypt growth by non-steroidal anti-inflammatory agents and differentiation agents in the rat colon. Int. J. Cancer, 60, 515-519.
22. Stopera, S.A. and Bird, R.P. (1993) Effects of all-trans retinoic acid as a potential chemopreventive agent on the formation of azoxymethane-induced aberrant crypt foci: differential expression of c-myc and c-fos mRNA and protein. Int. J. Cancer, 53, 798-803.
23. Zheng, Y., Kramer, P.M., Olson, G., Lubet, R.A., Steele, V.E., Kelloff, G.J. and Pereira, M.A. (1997) Prevention of by retinoids of azoxymethane-induced tumors and aberrant crypt foci and their modulation of cell proliferation in the colon of rats. Carcinogenesis, 18, 2119-2125.
24. 3 thymidine incorporation in mucosa of multiple polyposis. J. Clin. Invest., 42, 1922-1928.
25. Deschner, E.E. and Lipkin, M. (1975) Proliferative patterns in colonic mucosa in familial polyposis. Cancer, 35, 413-418.
26. Scalmati, A. and Lipkin, M. (1993) Proliferation and differentiation biomarkers in colorectal mucosa and their application to chemoprevention studies. Environ. Health Perspect., 99, 169-173.
27. Kelloff, G.J., Boone, C.W., Steele, V.E., Fay, J.R., Lubet, R.A., Crowell, J.A. and Sigrnan, C.C. (1994) Mechanistic considerations in chemopreventive drug development. J. Cell. Biochem., 20 (Suppl.), 1-24.
28. Deschner, E.E. and Lipkin, M. (1975) Proliferative patterns in colonic mucosa in familial polyposis. Cancer, 35, 413-418.
29. Thompson, C.B. (1995) Apoptosis in the pathogenesis and treatment of disease. Science, 267, 1456-1462.
30. Lotan, R. (1995) Retinoids and apoptosis: implications for cancer chemoprevention and therapy. J. Natl Cancer Inst., 87, 1655-1657.
31. Sporn, M.B. and Roberts, A.B. (1991) Interactions of retinoids and transformation growth factor-beta in regulation of cell differentiation and proliferation. Mol. Endocrinol., 5, 3-7.
32. Wyllie, A.H., Kerr, J.F. and Currie, A.R. (1980) Cell death, the significance of apoptosis. Int. Rev. Cytol., 68, 251-306.
33. Miller, S.A., Dykes, D.D. and Polesky, H.F. (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res., 16, 1215.
34. Williams, G.T. (1991) Programmed cell death: apoptosis and oncogenesis. Cell, 65, 1097-1098.
35. Schulte-Hermann, R., Parzefall, W., Bursch, W. and Timmerman-Trosiener, I. (1989) Hepatocarcinogenesis by non-genotoxic compounds. In Travis, C. (ed.) Biologically Based Methods far Cancer Risk Assessment. Plenum Press, New York, pp. 155-163.
36. Cohen, S.M. (1995) Role of cell proliferation in regenerative and neoplastic disease. Toxicol. Lett., 82/83, 15-21.
37. Moolgackar, S.H. (1993) Cell proliferation and carcinogenesis model: general principles with illustrations from the rodent liver system. Environ. Health Perspect., 101 (Suppl. 5), 91-94.
38. Allen, R.T., Hunter, W.J. and Agrawal, D.K. (1997) Morphological and biochemical characterization and analysis of apoptosis. J. Pharm. Toxicol. Methods, 37, 215-218.
39. Wright, S.C., Kumar, P., Tam, A.W., Shen, N., Varma, M. and Larrick, J.W. (1992) Apoptosis and DNA fragmentation precede TNF-induced cytolysis in U937 cells. J. Cell. Biochem., 48, 344-355.
40. Mangelsdorf, D.J., Umesone, K. and Evans, R.M. (1994) The retinoid receptors. In Sporn, M.B., Roberts, A.B. and Goodman, D.S. (eds.) The Retinoids: Biology, Chemistry and Medicine, 2nd edn. Raven Press, New York, pp. 319-349.
41. Sheikh, M.S., Shao, Z.-M., Li, X.-S. et al. (1995) N-(4-hydroxyphenyl)retinamide (4-HPR)-mediated biological actins involve retinoid-independent pathways in human breast carcinoma. Carcinogenesis, 16, 2477-2486.
42. Samaha, H.S., Kelloff, G.J., Steele, V., Rao, C.V. and Reddy, B.S. (1997) Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion. Cancer Res., 57, 1301-1305.